ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

Clinical trial NCT04267939 · TERMINATED

Trial details

NCT number: NCT04267939
Sponsor: Bayer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors (Excluding Prostate Cancer)Ovarian Cancer

Start date: 2020-02-26
Primary completion: 2023-12-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.